1. Home
  2. FNWD vs ANTX Comparison

FNWD vs ANTX Comparison

Compare FNWD & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

SELL

Current Price

$41.93

Market Cap

187.1M

Sector

Finance

ML Signal

SELL

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.38

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
ANTX
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.1M
172.9M
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
FNWD
ANTX
Price
$41.93
$3.38
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
7.2K
★ 321.9K
Earning Date
10-29-2026
11-11-2026
Dividend Yield
★ 1.15%
N/A
EPS Growth
N/A
★ 32.56
EPS
★ 1.00
N/A
Revenue
N/A
N/A
Revenue This Year
$10.81
N/A
Revenue Next Year
$5.26
N/A
P/E Ratio
$41.79
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.05
$1.00
52 Week High
$45.90
$7.19

Technical Indicators

Market Signals
Indicator
FNWD
ANTX
Relative Strength Index (RSI) 48.49 22.69
Support Level $41.49 $2.87
Resistance Level $44.01 $5.21
Average True Range (ATR) 0.71 0.41
MACD 0.02 -0.18
Stochastic Oscillator 55.07 2.23

Price Performance

Historical Comparison
FNWD
ANTX

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company that engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Savings Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out throughout the United States. The Company operates as a single reportable segment that derives its revenue mainly from the business of banking.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: